Antidepressant therapy in pregnancy: A review from the literature and report of a suspected paroxetine withdrawal syndrome in a newborn;Rischi da farmaci antidepressivi in gravidanza: Revisione della letteratura e presentazione di un caso di sospetta sindrome da astinenza da paroxetina in neonato

Rivista Italiana di Pediatria

Volumn 25, Issue 1, 1999, Pages 216-218

  Gerola, O ^a   Fiocchi, S ^a   Rondini, G ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Antidepressants; Newborn; Paroxetine; Withdrawal syndrome

Indexed keywords

ANTIDEPRESSANT AGENT; CLOMIPRAMINE; FLUOXETINE; IMIPRAMINE; NORTRIPTYLINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; ARTICLE; CASE REPORT; DEPRESSION; DIARRHEA; FEMALE; FETOMATERNAL TRANSFUSION; HUMAN; HUNGER; INSOMNIA; MATERNAL TREATMENT; MUSCLE HYPERTONIA; NERVOUSNESS; NEWBORN; PREGNANCY; RISK; WITHDRAWAL SYNDROME;

EID: 0032951440     PISSN: 03925161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. McElhatton PR, Garbis HM, Eléfant E, et al. The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants. A collaborative study of the European Network of Theratology Information Services (ENTIS). Reproductive Toxicology 1996;10:285.
2. Chambers CD, Johnson KA, Jones KL. Pregnancy outcome in women exposed to fluoxetine. Reprod Toxicol 1993;7:155.
3. Chambers CD, Kathleen BA, Johnson BA, et al. Birth outcomes in pregnant women taking fluoxetine. NEJM 1996;335:1010.
4. Goldstein DJ, Corbin LA, Sundell KL. Effects of first- trimester fluoxetine exposure on the newborn. Obstet Gynecol 1997;89:713.
5. Inman W, Kubota K, Pearce G e Wilton L. PEM Report Number 6. Paroxetine. Pharmacoepidemiol and Drug Sabety 1993;2:393.
6. Kulin NA, Pastuszak A, Sage SR, et al. Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: A prospective controlled multicentter study. JAMA 1998;279:60.
7. Pastuszak A, Schick Boschetto B, Zuber C, et al. Pregnancy outcome following first trimester exposure to fluoxetine (Prozac). JAMA 1993;269:2246.
8. Nulman I, Rovet J, Stewart DE, et al. Neurodevelopment of children exposed in utero to antidepressant drugs. NEJM 1997;336:258.
9. Eggermont E, Raveschot J, Deneve V e Casteels-Vandeele M. The adverse influence of imipramine on the adaptation of the newborn infant to extrauterine life. Acta Paediatr Belg 1972;26:197.
10. Shearer WT, Schreiner RL, Marshall RE. Urinary retention,.in a neonate secondary to maternal ingestion of nortriptyline. J Fed 1972;81:570.
11. Webster PAC. Withdrawal symptoms in neonates associated with maternal antidepressant therapy. Lancet 1993;II:318.
12. Ben Musa A. Neonatal effects of maternal clomipramine therapy. Arch Dis Child 1979;54:405.
13. Cowe L, Lloyd DJ, Dawling S. Neonatal convulsions caused by withdrawal from maternal clomipramine. Br Med J 1982;284:1837.
14. Zahle Ostergaard G, Pedersen SE. Neonatal effects of maternal clomipramine treatment. Pediatrios 1982;69:233.
15. Schimmell MS, Katz EZ, Shaag Y, et al. Toxic neonatal effects following maternal clomipramine therapy. Clin Toxicol 1991;29:479.
16. Singh S, Gulati S, Narang A, Bhakoo ON. Nonnarcotic withdrawal syndrome in a neonate due to maternal clomipramine therapy. J Paediatr Child Health 1990;26:110.
17. Spencer MJ, Escondido CA. Fluoxetine hydrochloride (Prozac) toxicity in a neonate. Pediatrics 1993;92:721.
18. Kent LSW, Laidlaw JDD. Suspected congenital sertraline dependence. Brit J of Psychiarty 1995;167:412.
19. Dahl ML, Olhager E, Ahlner J. Paroxetine withdrawal syndrome in a neonate. Brit J of Psychiatry 1997;171:391.
20. Pyke RE. Paroxetine withdrawal syndrome. Letter. Am J Psychiatry 1995;152:149.
21. Thomas DR, Nelson DR, Johnson AM. Biochemical effects of the antidepressant paroxetine, a specif∼c 5-hydroxyitryptamine uptake inhibitor. Psychopharmacology 1987;93:193.